60Q.F CAPTOR THHERAP. ZY-10
- Market cap
- -
- P/E
- -
- P/B
- 4.99x
- ROE
- -70.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 60Q.F undervalued?
Graham numberThe Graham number of CAPTOR THHERAP. ZY-10 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CAPTOR THHERAP. ZY-10 fundamental analysis
No fundamental analysis for CAPTOR THHERAP. ZY-10 yet.
CAPTOR THHERAP. ZY-10 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
CAPTOR THHERAP. ZY-10 financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
CAPTOR THHERAP. ZY-10 annual financial statements (PLN; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 3.99M | 9.16M | 13.2M | 15.8M | 4.66M | 3.92M |
| Gross Profit | 3.25M | 7.07M | 6.90M | 10.6M | 3.22M | 3.58M |
| Operating Income | -32.7M | -40.4M | -73.0M | -39.0M | -43.6M | -48.4M |
| EBITDA | - | -28.5M | -64.8M | -33.0M | -37.4M | -41.7M |
| Net Income | -32.6M | -35.9M | -70.6M | -38.4M | -42.0M | -45.5M |
| EPS | -7.89 | -8.61 | -15 | -6.99 | -7.62 | -7.19 |
| Balance Sheet | ||||||
| Total Assets | 144M | 113M | 97.3M | 87.5M | 40.0M | 79.5M |
| Total Liabilities | 19.3M | 16.7M | 28.1M | 23.0M | 16.5M | 14.5M |
| Shareholders' Equity | 124M | 96.3M | 69.2M | 64.5M | 23.5M | 65.1M |
| Cash & Short-term Investments | 118M | 71.0M | 75.7M | 39.3M | 10.7M | 2.40M |
| Cash Flow | ||||||
| Operating Cash Flow | -28.5M | -22.9M | -52.2M | -31.9M | -37.3M | -49.3M |
| Capital Expenditure | 5.11M | 892K | 3.01M | 424K | 210K | 470K |
| Free Cash Flow | -33.6M | -23.8M | -55.2M | -32.3M | -37.5M | -49.7M |
| Ratios | ||||||
| ROE | -26.2% | -37.3% | -102.0% | -59.6% | -178.9% | -70.0% |
| ROA | -22.7% | -31.8% | -72.5% | -43.9% | -104.9% | -57.2% |
| Net Profit Margin | -817.2% | -391.9% | -534.7% | -242.8% | -901.2% | -1,160.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
CAPTOR THHERAP. ZY-10 dividends
CAPTOR THHERAP. ZY-10 has not paid dividends in the last 5 fiscal years.
Who owns CAPTOR THHERAP. ZY-10
Ownership data of CAPTOR THHERAP. ZY-10 is not available yet.
CAPTOR THHERAP. ZY-10 company profile
- Company name
- CAPTOR THHERAP. ZY-10
- Ticker
- 60Q.F
- ISIN
- PLCPTRT00014
- Exchange
- Frankfurt Exchange
- Sector
- -
- Industry
- -
- Fiscal year end
- December
- Address
- Website
- -